Eligible patients may pay as little as $0 for OCTAGAM 10%*
*Eligible, commercially insured patients may pay as little as $0 for OCTAGAM 10% and may receive a maximum benefit of $12,500 per calendar year or the cost of patient’s co-pay in a 12-month period (whichever is less) for claims received by the program. Terms and conditions/eligibility requirements apply. See full terms and conditions here.
For eligible patients prescribed OCTAGAM 10%, the co-pay program is available through specialty infusion pharmacies.
What is Pfizer IGuide™?
Visit PfizerIGuide.com for help with enrollment, financial assistance, and
insurance support services.
Financial Assistance
Commercially Insured Patients
Medicare/Government-Insured Patients
Uninsured Patients
The Pfizer OCTAGAM Co-Pay Program Terms and Conditions for Patients
- Patients are not eligible to use this card if they are enrolled in a state or federally funded insurance program, including but not limited to Medicare, Medicaid, TRICARE, Veterans Affairs health care, a state prescription drug assistance program, or the Government Health Insurance Plan available in Puerto Rico (formerly known as “La Reforma de Salud”).
- Patient must have private insurance. Offer is not valid for cash paying patients. The value of this co-pay card is limited to a maximum of $12,500 per calendar year or the cost of patient co-pay in a 12-month period, whichever is less.
- This co-pay card is not valid when the entire cost of your prescription drug is eligible to be reimbursed by your private insurance plan or other private health or pharmacy benefit programs.
- You must deduct the value of this co-pay card from any reimbursement request submitted to your private insurance plan, either directly by you or on your behalf.
- You are responsible for reporting use of the co-pay card to any private insurer, health plan, or other third party who pays for or reimburses any part of the prescription filled using the co-pay card, as may be required. You should not use the co-pay card if your insurer or health plan prohibits use of manufacturer co-pay cards.
- Patient must be 18 years of age or older to be eligible for the co-pay benefit for Octagam 10% and 2 years of age or older to be eligible for the co-benefit for Octagam 5%.
- This co-pay card is not valid where prohibited by law.
- The benefit under the co-pay card program is offered to, and intended for the sole benefit of, eligible patients and may not be transferred to or utilized for the benefit of third parties, including, without limitation, third party payers, pharmacy benefit managers, or the agents of either.
- Co-pay card cannot be combined with any other savings, free trial or similar offer for the specified prescription cannot be combined with any other savings, free trial or similar offer for the specified prescription (including any program offered by a third party payer or pharmacy benefit manager, or an agent of either, that adjusts patient cost-sharing obligations, through arrangements that may be referred to as “accumulator” or “maximizer” programs).
- Third party payers, pharmacy benefit managers, or the agents of either, are prohibited from assisting patients with enrolling in the [coupon/co-pay card] program.
- Co-pay card will be accepted only at participating pharmacies.
- If your pharmacy does not participate, you may be able to submit a request for a rebate in connection with this offer.
- This co-pay card is not health insurance.
- Offer good only in the U.S. and Puerto Rico.
- Co-pay card is limited to 1 per person during this offering period and is not transferable.
- A co-pay card may not be redeemed more than once per 30 days per patient.
- No other purchase is necessary.
- No membership fee.
- Data related to your redemption of the co-pay card may be collected, analyzed, and shared with Pfizer for market research and other purposes related to assessing Pfizer's programs. Data shared with Pfizer will be aggregated and de-identified; it will be combined with data related to other co-pay card redemptions and will not identify you.
- Pfizer reserves the right to rescind, revoke or amend this offer without notice.
- Offer expires 12/31/2024.
Collapse
OCTAGAM 10% is indicated for the treatment of chronic immune thrombocytopenic purpura (cITP) in adults and dermatomyositis (DM) in adults. For patients with cITP, it is used to rapidly increase the platelet count in the blood to help control or prevent bleeding. For patients with DM, it helps improve muscle function and skin rash.
OCTAGAM 10% is a liquid medication that contains Immunoglobulin G (IgG). OCTAGAM 10% is made from human plasma donated by healthy people. OCTAGAM 10% is given through the vein (intravenously) in a hospital, infusion center, or at home.
Common side effects include headache, fever, nausea, vomiting, increased blood pressure, chills, musculoskeletal pain, dyspnea, infusion site reactions, and increased heart rate.
If you use a blood glucose monitor, check with your HCP to ensure that your monitor and test strips are acceptable to use while you are receiving OCTAGAM 10%.
These are not all of the possible side effects with OCTAGAM 10%. Tell your HCPs about any side effects that you have that cause concern or don't go away.
Please click here for Full Prescribing Information, including complete BOXED WARNING.
Patients should always ask their doctors for medical advice about adverse events.
You may report an adverse event related to Pfizer products by calling 1-800-438-1985 (US only). If you prefer, you may contact the US Food and Drug Administration (FDA) directly. The FDA has established a reporting service known as MedWatch where healthcare professionals and consumers can report problems they suspect may be associated with the drugs and medical devices they prescribe, dispense, or use. Visit www.fda.gov/MedWatch or call 1-800-FDA-1088.
OCTAGAM® is a registered trademark of Octapharma AG.
This site is intended only for U.S. residents. The products discussed in this site may have different product labeling in different countries. The information provided is for educational purposes only and is not intended to replace discussions with a healthcare provider.
Pfizer
PO Box 29309
Mission, KS 66201
Manufactured by Octapharma Pharmazeutika Produktionsges m.b.H.
Distributed by
Octapharma USA Inc.
PP-OTG-USA-0269-01
© 2023 Pfizer Inc.
December 2023
Expand
OCTAGAM 10% is indicated for the treatment of chronic immune thrombocytopenic purpura (cITP) in adults and dermatomyositis
(DM) in adults. For patients with cITP, it is used to rapidly increase the platelet count in the blood to
help control or prevent bleeding. For patients with DM, it helps improve muscle function and skin rash.
OCTAGAM 10% is a liquid medication that contains Immunoglobulin G (IgG). OCTAGAM 10% is made from human plasma donated by healthy people. OCTAGAM 10% is given through the vein (intravenously) in a hospital, infusion center, or at home.